Jeil Pharma Holdings Inc (002620.KS) KSC
7,390.00
-110(-1.47%)
Currency In KRW
- General
- Statistics
- Historical Data
- Profile
- Financials
Jeil Pharma Holdings Inc
Address
343, Sapyeong-daero
Seoul, 06543
Korea (the Republic of)
Phone
82 2 549 7451
Website
Sector
Healthcare
Industry
Drug Manufacturers - Specialty & Generic
Employees
35
First IPO Date
January 04, 2000
Key Executives
| Name | Title | Pay | Year Born |
| Seung-Soo Han | Chairman of The Board and Chief Executive Officer | 0 | 1947 |
Description
Jeil Pharma Holdings Inc manufactures and sells ingredients of drugs, incrementally modified drugs, and generic drugs in South Korea. The company offers active pharmaceutical ingredients in the areas of antibiotics, gastrointestinal, cardiovascular, neuropsychiatry, oncology, endocrinology, urology, antiviral, and antihistamines, as well as patch products. It also provides finished dosage forms in the areas of anti-bacteria and anti-fungal, anti-virus, cardiovascular, endocrinology, neurology, gastrointestinal, urology, oncology, anti-histamine, rheumatology, respiratory, otolaryngological, heaptic, laxatives, and purgatives. The company exports its products to approximately 40 countries in the Association of Southeast Asian Nations, Central and South America, Africa, etc. Jeil Pharma Holdings Inc was founded in 1959 and is headquartered in Seoul, South Korea.